All research
2026-07-12 PubMed

GLP-1 receptor agonist use and overall survival among women with type 2 diabetes and breast cancer: a retrospective cohort study.


Summary withdrawn

TitrateLab removes an AI-written study summary when it states findings we cannot trace to the study's own record, or when the study falls outside the compounds we track. Read the original record through the link above.


glp-1ra type-2-diabetes breast-cancer overall-survival cohort-study mortality
Source: pubmed:42434976 · Ingested Jul 12, 2026